News about Market

Pharmaceutical Inspection Machines Market to Reach USD 1.66 Billion by 2030: Report

The pharmaceutical inspection machines market is undergoing rapid transformation, driven by digital transformation, regulatory pressures, and increased demand for production agility.

Market | 19/08/2025 | By Dineshwori |  199

Accord BioPharma Launches IMULDOSA Prefilled Syringes at Lowest WAC Price

Accord BioPharma has announced the commercial launch of IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA (ustekinumab).

Market | 19/08/2025 | By Dineshwori |  512

Glenmark Eyes 10-15 percent India Growth by Prioritising High-Margin Branded Products

Glenmark Pharmaceuticals is targeting a compounded annual growth rate (CAGR) of 10–15 % for its India business over the next two to three years by shifting its focus up the value chain and expanding its portfolio of high-margin branded products.

Market | 19/08/2025 | By Darshana |  144

Aurobindo Pharma's China Manufacturing Plant to Reach EBITDA Break-Even by Q3 FY26

The facility began operations in late November 2024 and is currently ramping up production. With an initial annual capacity exceeding two billion units, it has already started production and invoicing between Q4 FY25 and Q1 FY26. The company has invested approximately USD 145 million in setting up the plant.

Market | 18/08/2025 | By Darshana |  254

Manufacturing and Market Risks Mount as Scorpion Capital Bets Against Soleno's PWS Therapy

The hedge fund cited issues with Vykat XR, Soleno’s recently approved treatment for Prader-Willi syndrome, citing risks of fluid accumulation in the lungs and potential heart failure. Scorpion also suggested that the drug could eventually be withdrawn from the market.

Market | 17/08/2025 | By Darshana |  254

Navamedic Sees Over 48% YoY Growth in Antibiotics Sales Boosted by Tender Wins

During the second quarter, Navamedic’s Hospital business delivered strong growth, driven primarily by Nordic tender wins in its antibiotics portfolio.

Market | 14/08/2025 | By Dineshwori |  177

US Antibody Drug Conjugates Market projected to Surpass USD 11 billion by 2034

The growth of US antibody drug conjugates (ADCs) market is driven by the rising investments in ADC research and development for discovering and developing novel and targeted cancer therapies.

Market | 13/08/2025 | By Dineshwori |  160

Senores Pharmaceuticals to Acquire Two ANDAs from Teva in USD 120 Million Market Opportunity

Senores Pharmaceuticals (SPL), through its wholly-owned US subsidiary Senores Pharmaceuticals, USA (SPI), has signed an agreement to acquire two USFDA-approved Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA.

Market | 13/08/2025 | By Darshana |  235

Abbott's US Diagnostics Sales Decline in Q2 Due to Falling COVID-19 Test Demand: GlobalData

Abbott Laboratories has continued to demonstrate steady performance in the US medical device market amid market shifts, though its diagnostics segment experienced a modest decline, according to new insights from GlobalData, a leading data and analytics firm.

Market | 12/08/2025 | By Dineshwori |  575

Medistep Healthcare to Launch INR 16.1 Crore SME IPO on August 8

Gujarat-based SME pharmaceutical products trader Medistep Healthcare will open its initial public offering (IPO) for subscription on 8 August, becoming the third company to launch an IPO on the same day, alongside ANB Metal Cast and Star Imaging & Path Lab. The offer will close on 12 August, with the issue price fixed at INR 43 per share.

Market | 11/08/2025 | By Darshana |  378